Skip to content
Search

Latest Stories

PSNC reminds contractors it'll be mandatory from July to send all script returns via MYS portal

The Pharmaceutical Services Negotiating Committee (PSNC) has informed that all prescription returns/referred back items and disallowed items will be received through the Manage Your Services (MYS) portal and submitted for payment using the same route from July 2022 (for the dispensing month of June 2022).

At present, using the MYS portal to receive referred back and disallowed items is optional with nearly half of all contractors signed up to receive these digitally. The remaining contractors currently receive their referred back and disallowed items in the post from the NHSBSA.


From July 2022, MYS will be the only route available to view and submit required information for all referred back and disallowed items. For those still using the paper-based route, the final paper referred back and disallowed items that will be sent through the post will relate to prescriptions dispensed in May 2022.

NHSBSA will process any paper referred back items that were sent out before the switchover. Contractors with paper referred back items from previous months should aim to complete the required information and return these to the NHSBSA together with their monthly prescription bundle as soon as possible to avoid any delays to payment. These returns will be processed in line with the guidance for the original submission method.

Using MYS for receiving digital referred back and disallowed items means contractors:

  • receive these items sooner;
  • can provide information required to processes referred back items faster;
  • can submit a challenge for any disallowed items electronically;
  • can track the progress of any referred back items throughout until the point they are processed; and
  • do not risk losing these items in transit.

Pharmacy contractors wishing to sign up to receive digital referred backs and disallowed items earlier than the July 2022 switchover should contact the MYS team by emailing nhsbsa.mys@nhs.net or via telephone 0300 330 1368 to enable access to these features on the MYS portal.

Once these features are enabled on MYS, paper referred back and disallowed items will no longer be posted to the pharmacy.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less